|
TTLL5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.29139999999395E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84259999999048E-05 |
| Normal-vs-Stage2 |
3.902000E-03 |
| Normal-vs-Stage3 |
1.049430E-04 |
| Normal-vs-Stage4 |
4.10010000000405E-05 |
| Stage1-vs-Stage2 |
6.484600E-01 |
| Stage1-vs-Stage3 |
9.111200E-01 |
| Stage1-vs-Stage4 |
5.785200E-01 |
| Stage2-vs-Stage3 |
6.356000E-01 |
| Stage2-vs-Stage4 |
4.458000E-01 |
| Stage3-vs-Stage4 |
7.014200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.12509999999444E-05 |
| Normal-vs-AfricanAmerican |
1.112410E-02 |
| Normal-vs-Asian |
1.057660E-03 |
| Caucasian-vs-AfricanAmerican |
9.284800E-01 |
| Caucasian-vs-Asian |
7.142600E-01 |
| AfricanAmerican-vs-Asian |
8.979400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.29450000000164E-05 |
| Normal-vs-Female |
1.59927999999754E-05 |
| Male-vs-Female |
8.293800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.6864999999997E-05 |
| Normal-vs-Age(41-60Yrs) |
3.350100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.81030000001581E-06 |
| Normal-vs-Age(81-100Yrs) |
1.065960E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.406400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.995200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.036800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.766650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.532200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.668000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.011800E-02 |
| Classical-VS-Follicular |
1.639690E-02 |
| Classical-VS-Other |
2.219600E-01 |
| Classical-VS-Normal |
3.358100E-04 |
| Tall-VS-Follicular |
8.739600E-01 |
| Tall-VS-Other |
7.637800E-01 |
| Tall-VS-Normal |
1.447490E-04 |
| Follicular-VS-Other |
7.027000E-01 |
| Follicular-VS-Normal |
3.7144000000211E-06 |
| Other-VS-Normal |
1.305740E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.26489999999302E-05 |
| Normal-vs-N1 |
1.89634999999688E-05 |
| N0-vs-N1 |
4.937200E-01 |
|
|
